Not known Factual Statements About sodium pentobarbital pentobarbital

Not known Factual Statements About sodium pentobarbital pentobarbital

Blog Article

pentobarbital will lessen the level or effect of naloxegol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with strong CYP3A4 inducers is not advisable

pentobarbital will reduce the level or effect of sunitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

pentobarbital will lower the extent or effect of theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

pentobarbital will decrease the level or effect of aprepitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

Observe Closely (1)pentobarbital will minimize the level or effect of mestranol by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will lessen the level or effect of ramelteon by impacting hepatic enzyme CYP2C9/10 metabolism. Minimal/Importance Unknown.

pentobarbital will reduce the extent or effect of sulfamethoxazole by impacting hepatic enzyme CYP2C9/ten metabolism. Minimal/Significance Not known.

pentobarbital will lower the level or effect of buspirone by impacting hepatic/intestinal enzyme click here CYP3A4 metabolism. Use Caution/Check.

pentobarbital will lower the extent or effect of artemether/lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration with powerful CYP3A4 inducers may lead to diminished serum concentrations and lack of antimalarial efficacy

Corticosteroids: Barbiturates look to improve the metabolism of exogenous corticosteroids possibly with the induction of hepatic microsomal enzymes. People stabilized on corticosteroid therapy could involve dosage adjustments if barbiturates are additional to or withdrawn from their dosage program.

pentobarbital will minimize the level or effect of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is actually a delicate CYP3A4 substrate. Coadministration with solid or moderate CYP3A4 inducers is contraindicated.

pentobarbital will minimize the extent or effect of terbinafine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

pentobarbital will lower the level or effect of tofacitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Lack of, or decreased response to tofacitinib might arise when coadministered with powerful CYP3A4 inducers

pentobarbital will decrease the level or effect of midazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.